A Dose-finding Phase I/II Trial of Daunorubicin and Cytarabine Combined to Fractionated Mylotarg(R) as Re-induction Treatment in Patients With First Relapse of Acute Myeloid Leukemia

Trial Profile

A Dose-finding Phase I/II Trial of Daunorubicin and Cytarabine Combined to Fractionated Mylotarg(R) as Re-induction Treatment in Patients With First Relapse of Acute Myeloid Leukemia

Completed
Phase of Trial: Phase I/II

Latest Information Update: 24 Jul 2014

At a glance

  • Drugs Gemtuzumab ozogamicin (Primary) ; Amsacrine; Cytarabine; Daunorubicin
  • Indications Acute myeloid leukaemia
  • Focus Adverse reactions
  • Acronyms MYLOFRANCE2
  • Most Recent Events

    • 24 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top